Pharma News

Gilead to evaluate remdesivir in pediatric Covid-19 patients

Gilead to evaluate remdesivir in pediatric Covid-19 patients

Gilead Sciences is set to direct a Phase II/III cl

Alembic Pharma gains 6% on USFDA gesture for its iron tablet

Alembic Pharma gains 6% on USFDA gesture for its iron tablet

The portions of Alembic Pharmaceuticals picked up

AstraZeneca COVID-19 vaccine liable to ensure for a year: CEO

AstraZeneca COVID-19 vaccine liable to ensure for a year: CEO

AstraZeneca's potential coronavirus immunization i